Visualitzant VHIO - Articles científics per títol
Ara mostrant els elements 667-686 d 867
-
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
(American Society for Microbiology, 2022-06) -
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura
(American Society of Hematology, 2022-12-27) -
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
(American Society of Hematology, 2022-06-28) -
Recent advances in the targeting of epigenetic regulators in b-cell non- Hodgkin lymphoma
(Frontiers Media, 2019-10-16) -
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma
(Cold Spring Harbor Laboratory Press, 2023-04-01) -
Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study
(American Society of Clinical Oncology, 2023-10-20) -
Reporting reimbursement price decisions for onco-hematology drugs in Spain
(Frontiers Media, 2023-10-24) -
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
(Springer Nature, 2020-09) -
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
(American Association for Cancer Research, 2023-03-01)